Bloomberg Law
Aug. 11, 2020, 10:36 PM

Moderna, U.S. Reach Deal for 100 Million Covid-19 Vaccine Doses

Olivia Raimonde
Olivia Raimonde
Bloomberg News
Robert Langreth
Robert Langreth
Bloomberg News

Moderna Inc. reached a deal with the Trump administration to supply 100 million doses of its experimental vaccine for Covid-19, in a pact valued at up to $1.5 billion, the latest in a string of supply agreements the U.S. has reached to stockpile the most advanced vaccines in testing.

“I’m pleased to announce we’ve reached an agreement with Moderna to manufacture and deliver 100 million doses of the coronavirus vaccine candidate,” President Donald Trump said at a White House briefing. “The federal government will own these vaccine doses, we’re buying them.”

Watch: President Donald Trump says the U.S. has reached a deal with Moderna Inc. to manufacture and distribute 100 million doses of its experimental vaccine for Covid-19.
(Source: Bloomberg)

Moderna, which is already receiving $955 million in ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.